3-Chloro-PCP (3'-Cl-PCP) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has comparable potency to phencyclidine but with a slightly different effects profile, being somewhat more potent as an NMDA antagonist but around the same potency as a dopamine reuptake inhibitor.[1] It was first identified in Slovenia in December 2020,[2] and was made illegal in Hungary in April 2021.[3]

3-Chloro-PCP
Legal status
Legal status
Identifiers
  • 1-[1-(3-chlorophenyl)cyclohexyl]piperidine
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H24ClN
Molar mass277.84 g·mol−1
3D model (JSmol)
  • C1CCC(CC1)(C2=CC(=CC=C2)Cl)N3CCCCC3
  • InChI=1S/C17H24ClN/c18-16-9-7-8-15(14-16)17(10-3-1-4-11-17)19-12-5-2-6-13-19/h7-9,14H,1-6,10-13H2
  • Key:HUHBTESMMFLCAN-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F (2020). "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry. 11: 632405. doi:10.3389/fpsyt.2020.632405. PMC 7900492. PMID 33633599.
  2. ^ "Analytical Report. 3Cl-PCP (C17H24ClN). 1-[1-(3-chlorophenyl)cyclohexyl]piperidine" (PDF). National Forensic Laboratory. Slovenia.
  3. ^ "Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU". Minister for Human Capacities. 30 December 2014.